生命科学资讯

Uniqure falls as FDA demands new trial for Huntington’s gene therapy

Med-tech outlook 2026: exits, financings, headwinds

Biggest gainers and losers for Feb. 23-27, 2026

Atrium Tx launches with Avidity's RNA ticker and cardio assets

Shionogi synthesizes new compounds for malaria

In the clinic for Feb. 27, 2026

Other news to note for Feb. 27, 2026

Regulatory actions for Feb. 27, 2026

Biopharma money raised: Jan. 1-Feb. 26, 2026

Money raised by biopharma

Changing US FDA trial default a global matter

Pivot Therapeutics develops new AKT1 inhibitors

MRGPRX2 antagonists disclosed in Arcus Biosciences patent

CSPC Zhongqi Pharmaceutical Technology discovers EGFR PROTAC degraders

Prospect Therapeutics identifies new JAK1 and TYK2 inhibitors